Viewing Study NCT04579666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-02-04 @ 12:30 PM
Study NCT ID: NCT04579666
Status: TERMINATED
Last Update Posted: 2025-04-24
First Post: 2020-09-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Apellis Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Amyotrophic Lateral Sclerosis View
None Motor Neuron Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amyotrophic Lateral Sclerosis View
None ALS View
None Motor Neuron Disease View
None APL-2 View
None APL2 View
None Pegcetacoplan View